Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Nexpoint Real Estate Finance, Inc. (NREF)
NYSEReal EstateReit - MortgageSnapshot 2026-11-05
$13.59-7.17%
Close 2026-11-05 · 1-day change
NYSEReal EstateReit - MortgageSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
1.75 → 1.73 EPS · FY ending Dec 31, 2027 · 3 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 2 to 3; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for NREF yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Secure new credit agreements totaling at least $395 million | A supporting condition in Nexpoint Real Estate Finance, Inc.'s published investment case. The stated target is >= $395 million total. | Improving | credit agreements fall below $395 million total by 2026-Q2 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a rate-sensitive real estate investment with a fragile earnings profile, rather than a proven durable compounder. The long-term thesis is insufficiently established: recent results show positive but declining net income, and the latest quarter was an earnings miss.
NREF is cheap versus peers, while the valuation evidence also points to a durable premium and a meaningful expectations gap. The evidence labels the fragility as low and unjustified, suggesting weak execution quality alone is not fully reflected in the market’s assumptions.
Near term, earnings risk is elevated after repeated recent misses, including the latest quarter. Management maintained the $0.50 dividend per share in both reported quarters and secured new credit agreements, but net income fell from $10.0 million in the first quarter to $5.4 million in the second, leaving execution mixed.
Over the next few quarters, the thesis hinges on whether NREF avoids a guidance cut and stabilizes earnings while sustaining its dividend and credit access. Fed rate cuts could support rate-sensitive real estate names, while weakness among sector peers could remove that support.
For a 1 to 3 year view, NREF combines a cheap valuation versus peers with fragile earnings and elevated near-term miss risk. The thesis remains uncertain and depends on improved execution and continued financial support. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| NREF keeps paying a $0.5 dividend per share. |
| Intact |
| dividend per share falls below $0.5 next quarter |
Dividend per share: $0.50 per share FY2026-Q2; GAAP. Published target: >= $0.5 per share. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 12, 20260.5 USD/share · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 of 3 supplied quarters. Management reported: “• On October 26, 2026 NREF announced a fourth quarter dividend of $0.50 per common share.” “• On July 27, 2026 NREF announced a third quarter dividend of $0.50 per common share 1 Weighted-average shares outstanding - diluted assumes vesting of all outstanding unvested restricted stock units and the conversion of all redeemable non-controlling interests.” Delivery assessment Nov 5, 2026 |
EPS near $0.34 per share next quarter | Earnings per share are expected near $0.34 next quarter. | Intact | EPS falls below $0.32 next quarter | Diluted EPS: $0.29 per share FY2026-Q2; GAAP. Published target: ~$0.34 per share. The target does not explicitly identify fiscal versus calendar quarters. Aug 12, 20260.29 USD/share · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 of 3 supplied quarters. Management reported: “• On October 26, 2026 NREF announced a fourth quarter dividend of $0.50 per common share.” “• On July 27, 2026 NREF announced a third quarter dividend of $0.50 per common share 1 Weighted-average shares outstanding - diluted assumes vesting of all outstanding unvested restricted stock units and the conversion of all redeemable non-controlling interests.” Delivery assessment Nov 5, 2026 |
Maintain positive net income near $22.6 million | It has positive net income around $22.6 million. | Intact | net income falls below $22 million next quarter | Net income: $17.299M FY2026-Q2; GAAP. Published target: >= $22 million. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 12, 202617,299,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$1.78 → $1.73 · observed estimates
$0.06B → $0.07B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $1.78 | $62,104,670 | 3 / 3 |
| 2026-07-25 | $1.78 | $62,104,670 | 3 / 3 |
| 2026-07-26 | $1.78 | $62,104,670 | 3 / 3 |
| 2026-07-27 | $1.78 | $61,460,000 | 2 / 2 |
| 2026-07-28 | $1.78 | $62,104,670 | 3 / 3 |
| 2026-07-29 | $1.78 | $62,104,670 | 3 / 3 |
| 2026-07-30 | $1.78 | $62,104,670 | 3 / 3 |
| 2026-07-31 | $1.78 | $62,104,670 | 3 / 3 |
| 2026-08-01 | $1.78 | $61,460,000 | 2 / 2 |
| 2026-08-02 | $1.78 | $62,104,670 | 3 / 3 |
| 2026-08-03 | $1.78 | $62,104,670 | 3 / 3 |
| 2026-08-04 | $1.78 | $61,460,000 | 2 / 2 |
| 2026-08-05 | $1.78 | $61,460,000 | 2 / 2 |
| 2026-08-06 | $1.78 | $62,104,670 | 3 / 3 |
| 2026-08-07 | $1.78 | $61,460,000 | 2 / 2 |
| 2026-08-08 | $1.75 | $64,230,330 | 3 / 3 |
| 2026-08-09 | $1.75 | $64,230,330 | 3 / 3 |
| 2026-08-10 | $1.75 | $64,230,330 | 3 / 3 |
| 2026-08-12 | $1.75 | $63,963,670 | 3 / 3 |
| 2026-08-13 | $1.78 | $61,460,000 | 2 / 2 |
| 2026-08-14 | $1.78 | $61,460,000 | 2 / 2 |
| 2026-08-15 | $1.78 | $61,460,000 | 2 / 2 |
| 2026-08-16 | $1.78 | $61,460,000 | 2 / 2 |
| 2026-08-17 | $1.78 | $61,460,000 | 2 / 2 |
| 2026-08-18 | $1.78 | $61,460,000 | 2 / 2 |
| 2026-08-19 | $1.78 | $61,460,000 | 2 / 2 |
| 2026-08-20 | $1.75 | $64,650,000 | 2 / 2 |
| 2026-08-21 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-08-22 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-08-23 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-08-24 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-08-25 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-08-26 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-08-27 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-08-28 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-08-29 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-08-30 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-08-31 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-01 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-02 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-03 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-04 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-05 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-06 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-07 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-08 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-09 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-10 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-11 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-12 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-13 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-14 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-15 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-16 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-17 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-18 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-19 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-20 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-21 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-22 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-23 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-24 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-25 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-26 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-27 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-28 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-29 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-09-30 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-10-01 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-10-02 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-10-03 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-10-04 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-10-05 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-10-06 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-10-07 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-10-08 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-10-09 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-10-10 | $1.75 | $67,900,000 | 2 / 2 |
| 2026-10-11 | $1.73 | $67,900,000 | 2 / 2 |
| 2026-10-12 | $1.73 | $67,900,000 | 2 / 2 |
| 2026-10-13 | $1.73 | $67,900,000 | 2 / 2 |
| 2026-10-14 | $1.73 | $67,900,000 | 2 / 2 |
| 2026-10-15 | $1.73 | $66,129,999 | 2 / 3 |
| 2026-10-16 | $1.73 | $66,129,999 | 2 / 3 |
| 2026-10-17 | $1.73 | $66,129,999 | 2 / 3 |
| 2026-10-18 | $1.73 | $66,129,999 | 2 / 3 |
| 2026-10-19 | $1.73 | $66,129,999 | 2 / 3 |
| 2026-10-20 | $1.73 | $66,129,999 | 2 / 3 |
| 2026-10-21 | $1.73 | $66,129,999 | 2 / 3 |
| 2026-10-22 | $1.73 | $66,129,999 | 2 / 3 |
| 2026-10-23 | $1.73 | $66,129,999 | 2 / 3 |
| 2026-10-24 | $1.73 | $66,129,999 | 2 / 3 |
| 2026-10-25 | $1.73 | $66,129,999 | 2 / 3 |
| 2026-10-26 | $1.73 | $66,129,999 | 2 / 3 |
| 2026-10-27 | $1.73 | $66,129,999 | 2 / 3 |
| 2026-10-28 | $1.73 | $66,129,999 | 2 / 3 |
| 2026-10-29 | $1.73 | $66,129,999 | 2 / 3 |
| 2026-10-30 | $1.73 | $66,129,999 | 2 / 3 |
| 2026-10-31 | $1.73 | $66,129,999 | 2 / 3 |
| 2026-11-01 | $1.73 | $66,129,999 | 3 / 3 |
| 2026-11-02 | $1.73 | $66,129,999 | 3 / 3 |
| 2026-11-03 | $1.73 | $66,129,999 | 3 / 3 |
| 2026-11-04 | $1.73 | $66,129,999 | 3 / 3 |
| 2026-11-05 | $1.73 | $66,129,999 | 3 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 0 Buy / Strong Buy · 3 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 1 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.